Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Bayer (ETR: BAYN) commits over C$45m to new Canadian canola innovation centre in Winnipeg Bayer is investing over CAD 45M in a new canola innovation centre in Winnipeg. Find out what it means for trait development, seed strategy, and R&D scale. bySrinathJanuary 27, 2026